Rifaximin: a nonabsorbed antimicrobial as a new tool for treatment of travelers' diarrhea.
Steffen
R
R
Institute of Social and Preventive Medicine, University of Zürich, Switzerland.
D000042:Absorption; D000890:Anti-Infective Agents / Q000008:administration & dosage / Q000493:pharmacokinetics / Q000627:therapeutic use*; D002986:Clinical Trials as Topic; D003967:Diarrhea / Q000517:prevention & control*; D004334:Drug Administration Schedule; D005765:Gastrointestinal Agents / Q000008:administration & dosage / Q000493:pharmacokinetics / Q000627:therapeutic use*; D006801:Humans; D012294:Rifamycins / Q000008:administration & dosage / Q000493:pharmacokinetics / Q000627:therapeutic use*; D000078262:Rifaximin; D014195:Travel; D016896:Treatment Outcome
D000890:Anti-Infective Agents; D005765:Gastrointestinal Agents; D012294:Rifamycins; D000078262:Rifaximin